<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" class="marks" width="521" height="285" viewBox="0 0 521 285"><rect width="521" height="285" fill="white"/><g fill="none" stroke-miterlimit="10" transform="translate(50,41)"><g class="mark-group role-frame root" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z" stroke-width="0"/><g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="X-axis titled 'Concentration (µg/mL)' for a log scale with values from 1e-4 to 1e+1"><g transform="translate(0.5,200.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(0,0)" x2="0" y2="4" stroke="black" stroke-width="1" opacity="1"/><line transform="translate(120,0)" x2="0" y2="4" stroke="black" stroke-width="1" opacity="1"/><line transform="translate(240,0)" x2="0" y2="4" stroke="black" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="middle" transform="translate(0,17)" font-family="Helvetica" font-size="14px" font-weight="normal" fill="#000" opacity="1">1e-4</text><text text-anchor="middle" transform="translate(120,17)" font-family="Helvetica" font-size="14px" font-weight="normal" fill="#000" opacity="1">1e-2</text><text text-anchor="middle" transform="translate(240,17)" font-family="Helvetica" font-size="14px" font-weight="normal" fill="#000" opacity="1">1e+0</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,0)" x2="300" y2="0" stroke="black" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-title" pointer-events="none"><text text-anchor="middle" transform="translate(150,36)" font-family="Helvetica" font-size="14px" font-weight="bold" fill="#000" opacity="1">Concentration (µg/mL)</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="Y-axis titled 'Fraction Infectivity' for a linear scale with values from 0.0 to 1.0"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(0,200)" x2="-4" y2="0" stroke="black" stroke-width="1" opacity="1"/><line transform="translate(0,100)" x2="-4" y2="0" stroke="black" stroke-width="1" opacity="1"/><line transform="translate(0,0)" x2="-4" y2="0" stroke="black" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(-6,204)" font-family="Helvetica" font-size="14px" font-weight="normal" fill="#000" opacity="1">0.0</text><text text-anchor="end" transform="translate(-6,104)" font-family="Helvetica" font-size="14px" font-weight="normal" fill="#000" opacity="1">0.5</text><text text-anchor="end" transform="translate(-6,4)" font-family="Helvetica" font-size="14px" font-weight="normal" fill="#000" opacity="1">1.0</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,200)" x2="0" y2="-200" stroke="black" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-title" pointer-events="none"><text text-anchor="middle" transform="translate(-30.4619140625,100) rotate(-90) translate(0,-3)" font-family="Helvetica" font-size="14px" font-weight="bold" fill="#000" opacity="1">Fraction Infectivity</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-scope layer_0_pathgroup" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z"/><g><g class="mark-line role-mark layer_0_marks" role="graphics-object" aria-roledescription="line mark container"><path aria-label="Concentration (µg/mL): 3e-4; Fraction Infectivity: 0.99978892881; Antibody: nAH1.3" role="graphics-symbol" aria-roledescription="line mark" d="M25.444,0.042L26.751,0.046L28.058,0.051L29.365,0.056L30.672,0.062L31.98,0.068L33.287,0.075L34.594,0.082L35.901,0.09L37.208,0.099L38.515,0.109L39.822,0.12L41.129,0.132L42.436,0.145L43.743,0.16L45.05,0.176L46.357,0.193L47.12,0.204L47.664,0.212L48.971,0.233L50.279,0.257L51.586,0.282L52.893,0.31L54.2,0.341L55.507,0.375L56.814,0.412L58.121,0.453L59.428,0.499L60.735,0.548L62.042,0.603L63.349,0.663L64.656,0.728L65.963,0.801L67.271,0.88L68.578,0.967L69.885,1.063L71.192,1.169L72.499,1.285L73.806,1.412L75.113,1.552L76.42,1.705L77.727,1.873L79.034,2.058L80.341,2.261L81.648,2.484L82.955,2.728L83.243,2.785L84.263,2.996L85.57,3.29L86.877,3.612L88.184,3.965L89.491,4.352L90.798,4.775L92.105,5.239L93.412,5.746L94.719,6.301L96.026,6.908L97.333,7.57L98.64,8.294L99.947,9.083L101.254,9.944L102.562,10.881L103.869,11.902L105.176,13.011L106.483,14.217L107.79,15.524L109.097,16.941L110.404,18.474L111.711,20.131L113.018,21.918L114.325,23.843L115.632,25.912L116.939,28.133L118.246,30.51L119.394,32.73L119.554,33.049L120.861,35.756L122.168,38.632L123.475,41.681L124.782,44.904L126.089,48.3L127.396,51.868L128.703,55.602L130.01,59.496L131.317,63.544L132.624,67.734L133.931,72.055L135.238,76.492L136.546,81.029L137.853,85.648L139.16,90.331L140.467,95.057L141.774,99.805L143.081,104.555L144.388,109.283L145.695,113.97L147.002,118.596L148.309,123.14L149.616,127.586L150.923,131.917L152.23,136.118L153.537,140.178L154.845,144.085L155.504,145.996L156.152,147.833L157.459,151.414L158.766,154.824L160.073,158.061L161.38,161.125L162.687,164.015L163.994,166.735L165.301,169.288L166.608,171.679L167.915,173.912L169.222,175.993L170.529,177.93L171.837,179.728L173.144,181.395L174.451,182.938L175.758,184.364L177.065,185.68L178.372,186.894L179.679,188.011L180.986,189.038L182.293,189.982L183.6,190.849L184.907,191.644L186.214,192.373L187.521,193.04L188.829,193.651L190.136,194.21L191.443,194.721L191.629,194.791L192.75,195.188L194.057,195.615L195.364,196.005L196.671,196.36L197.978,196.685L199.285,196.981L200.592,197.251L201.899,197.497L203.206,197.721L204.513,197.926L205.82,198.112L207.128,198.282L208.435,198.436L209.742,198.577L211.049,198.705L212.356,198.822L213.663,198.928L214.97,199.025L216.277,199.113L217.584,199.193L218.891,199.266L220.198,199.332L221.505,199.393L222.812,199.448L224.12,199.498L225.427,199.543L226.734,199.584L227.753,199.614L228.041,199.622L229.348,199.656L230.655,199.687L231.962,199.716L233.269,199.741L234.576,199.765L235.883,199.786L237.19,199.805L238.497,199.823L239.804,199.839L241.112,199.854L242.419,199.867L243.726,199.879L245.033,199.89L246.34,199.9L247.647,199.909L248.954,199.917L250.261,199.925L251.568,199.932L252.875,199.938L254.182,199.943L255.489,199.949L256.796,199.953L258.103,199.957L259.411,199.961L260.718,199.965L262.025,199.968L263.332,199.971L263.876,199.972L264.639,199.974L265.946,199.976L267.253,199.978L268.56,199.98L269.867,199.982L271.174,199.984L272.481,199.985L273.788,199.986L275.095,199.988L276.403,199.989L277.71,199.99L279.017,199.991L280.324,199.992L281.631,199.992L282.938,199.993L284.245,199.994L285.552,199.994" stroke="#ff9da7" stroke-width="1.5"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z"/><g><g class="mark-line role-mark layer_0_marks" role="graphics-object" aria-roledescription="line mark container"><path aria-label="Concentration (µg/mL): 3e-4; Fraction Infectivity: 0.999487336219; Antibody: m102.4" role="graphics-symbol" aria-roledescription="line mark" d="M25.444,0.103L26.751,0.113L28.058,0.125L29.365,0.138L30.672,0.152L31.98,0.168L33.287,0.186L34.594,0.205L35.901,0.226L37.208,0.25L38.515,0.276L39.822,0.305L41.129,0.337L42.436,0.372L43.743,0.41L45.05,0.453L46.357,0.5L47.12,0.53L47.664,0.552L48.971,0.609L50.279,0.672L51.586,0.742L52.893,0.819L54.2,0.904L55.507,0.998L56.814,1.101L58.121,1.216L59.428,1.341L60.735,1.48L62.042,1.633L63.349,1.802L64.656,1.988L65.963,2.193L67.271,2.418L68.578,2.667L69.885,2.941L71.192,3.242L72.499,3.574L73.806,3.939L75.113,4.341L76.42,4.782L77.727,5.268L79.034,5.801L80.341,6.386L81.648,7.028L82.955,7.732L83.243,7.896L84.263,8.504L85.57,9.348L86.877,10.273L88.184,11.283L89.491,12.386L90.798,13.589L92.105,14.899L93.412,16.325L94.719,17.875L96.026,19.555L97.333,21.376L98.64,23.343L99.947,25.466L101.254,27.752L102.562,30.207L103.869,32.838L105.176,35.65L106.483,38.648L107.79,41.833L109.097,45.207L110.404,48.769L111.711,52.517L113.018,56.446L114.325,60.547L115.632,64.812L116.939,69.229L118.246,73.782L119.394,77.877L119.554,78.454L120.861,83.228L122.168,88.082L123.475,92.993L124.782,97.938L126.089,102.894L127.396,107.835L128.703,112.739L130.01,117.58L131.317,122.338L132.624,126.992L133.931,131.524L135.238,135.915L136.546,140.154L137.853,144.227L139.16,148.125L140.467,151.842L141.774,155.373L143.081,158.716L144.388,161.869L145.695,164.835L147.002,167.617L148.309,170.218L149.616,172.644L150.923,174.902L152.23,176.998L153.537,178.94L154.845,180.737L155.504,181.59L156.152,182.395L157.459,183.923L158.766,185.329L160.073,186.621L161.38,187.806L162.687,188.893L163.994,189.889L165.301,190.799L166.608,191.631L167.915,192.391L169.222,193.084L170.529,193.716L171.837,194.292L173.144,194.817L174.451,195.295L175.758,195.729L177.065,196.125L178.372,196.484L179.679,196.81L180.986,197.107L182.293,197.377L183.6,197.621L184.907,197.843L186.214,198.045L187.521,198.228L188.829,198.394L190.136,198.544L191.443,198.681L191.629,198.699L192.75,198.804L194.057,198.917L195.364,199.018L196.671,199.111L197.978,199.194L199.285,199.27L200.592,199.339L201.899,199.401L203.206,199.457L204.513,199.508L205.82,199.555L207.128,199.597L208.435,199.635L209.742,199.669L211.049,199.7L212.356,199.728L213.663,199.754L214.97,199.777L216.277,199.798L217.584,199.817L218.891,199.835L220.198,199.85L221.505,199.864L222.812,199.877L224.12,199.889L225.427,199.899L226.734,199.909L227.753,199.915L228.041,199.917L229.348,199.925L230.655,199.932L231.962,199.939L233.269,199.944L234.576,199.95L235.883,199.954L237.19,199.959L238.497,199.963L239.804,199.966L241.112,199.969L242.419,199.972L243.726,199.975L245.033,199.977L246.34,199.979L247.647,199.981L248.954,199.983L250.261,199.985L251.568,199.986L252.875,199.987L254.182,199.989L255.489,199.99L256.796,199.991L258.103,199.992L259.411,199.992L260.718,199.993L262.025,199.994L263.332,199.994L263.876,199.995L264.639,199.995L265.946,199.995L267.253,199.996L268.56,199.996L269.867,199.997L271.174,199.997L272.481,199.997L273.788,199.997L275.095,199.998L276.403,199.998L277.71,199.998L279.017,199.998L280.324,199.998L281.631,199.999L282.938,199.999L284.245,199.999L285.552,199.999" stroke="#af7aa1" stroke-width="1.5"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z"/><g><g class="mark-line role-mark layer_0_marks" role="graphics-object" aria-roledescription="line mark container"><path aria-label="Concentration (µg/mL): 3e-4; Fraction Infectivity: 0.999903545802; Antibody: HENV-26" role="graphics-symbol" aria-roledescription="line mark" d="M25.444,0.019L26.751,0.022L28.058,0.024L29.365,0.027L30.672,0.031L31.98,0.035L33.287,0.039L34.594,0.044L35.901,0.049L37.208,0.056L38.515,0.062L39.822,0.07L41.129,0.079L42.436,0.089L43.743,0.1L45.05,0.112L46.357,0.126L47.12,0.135L47.664,0.142L48.971,0.16L50.279,0.18L51.586,0.202L52.893,0.228L54.2,0.256L55.507,0.288L56.814,0.324L58.121,0.364L59.428,0.409L60.735,0.46L62.042,0.518L63.349,0.582L64.656,0.654L65.963,0.736L67.271,0.827L68.578,0.93L69.885,1.045L71.192,1.175L72.499,1.32L73.806,1.484L75.113,1.667L76.42,1.873L77.727,2.105L79.034,2.364L80.341,2.655L81.648,2.981L82.955,3.347L83.243,3.433L84.263,3.757L85.57,4.215L86.877,4.729L88.184,5.303L89.491,5.945L90.798,6.662L92.105,7.462L93.412,8.354L94.719,9.348L96.026,10.453L97.333,11.681L98.64,13.044L99.947,14.552L101.254,16.221L102.562,18.062L103.869,20.089L105.176,22.315L106.483,24.755L107.79,27.419L109.097,30.322L110.404,33.471L111.711,36.877L113.018,40.545L114.325,44.479L115.632,48.677L116.939,53.137L118.246,57.848L119.394,62.181L119.554,62.799L120.861,67.971L122.168,73.341L123.475,78.882L124.782,84.563L126.089,90.347L127.396,96.197L128.703,102.073L130.01,107.935L131.317,113.743L132.624,119.457L133.931,125.043L135.238,130.466L136.546,135.699L137.853,140.717L139.16,145.501L140.467,150.036L141.774,154.312L143.081,158.324L144.388,162.07L145.695,165.552L147.002,168.777L148.309,171.751L149.616,174.484L150.923,176.989L152.23,179.277L153.537,181.361L154.845,183.255L155.504,184.143L156.152,184.973L157.459,186.528L158.766,187.932L160.073,189.198L161.38,190.338L162.687,191.364L163.994,192.285L165.301,193.111L166.608,193.852L167.915,194.515L169.222,195.108L170.529,195.639L171.837,196.113L173.144,196.537L174.451,196.915L175.758,197.253L177.065,197.554L178.372,197.822L179.679,198.061L180.986,198.275L182.293,198.464L183.6,198.634L184.907,198.784L186.214,198.918L187.521,199.038L188.829,199.144L190.136,199.239L191.443,199.323L191.629,199.334L192.75,199.398L194.057,199.464L195.364,199.524L196.671,199.576L197.978,199.623L199.285,199.665L200.592,199.702L201.899,199.735L203.206,199.764L204.513,199.791L205.82,199.814L207.128,199.834L208.435,199.853L209.742,199.869L211.049,199.884L212.356,199.896L213.663,199.908L214.97,199.918L216.277,199.927L217.584,199.935L218.891,199.942L220.198,199.949L221.505,199.955L222.812,199.96L224.12,199.964L225.427,199.968L226.734,199.972L227.753,199.974L228.041,199.975L229.348,199.978L230.655,199.98L231.962,199.982L233.269,199.984L234.576,199.986L235.883,199.988L237.19,199.989L238.497,199.99L239.804,199.991L241.112,199.992L242.419,199.993L243.726,199.994L245.033,199.995L246.34,199.995L247.647,199.996L248.954,199.996L250.261,199.997L251.568,199.997L252.875,199.997L254.182,199.998L255.489,199.998L256.796,199.998L258.103,199.998L259.411,199.998L260.718,199.999L262.025,199.999L263.332,199.999L263.876,199.999L264.639,199.999L265.946,199.999L267.253,199.999L268.56,199.999L269.867,199.999L271.174,199.999L272.481,200L273.788,200L275.095,200L276.403,200L277.71,200L279.017,200L280.324,200L281.631,200L282.938,200L284.245,200L285.552,200" stroke="#59a14f" stroke-width="1.5"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z"/><g><g class="mark-line role-mark layer_0_marks" role="graphics-object" aria-roledescription="line mark container"><path aria-label="Concentration (µg/mL): 3e-4; Fraction Infectivity: 0.999961502991; Antibody: HENV-32" role="graphics-symbol" aria-roledescription="line mark" d="M25.444,0.008L26.751,0.008L28.058,0.009L29.365,0.01L30.672,0.011L31.98,0.012L33.287,0.013L34.594,0.014L35.901,0.015L37.208,0.016L38.515,0.017L39.822,0.019L41.129,0.02L42.436,0.022L43.743,0.024L45.05,0.026L46.357,0.028L47.12,0.03L47.664,0.031L48.971,0.033L50.279,0.036L51.586,0.039L52.893,0.042L54.2,0.046L55.507,0.05L56.814,0.054L58.121,0.058L59.428,0.063L60.735,0.069L62.042,0.075L63.349,0.081L64.656,0.088L65.963,0.095L67.271,0.103L68.578,0.112L69.885,0.121L71.192,0.131L72.499,0.142L73.806,0.155L75.113,0.168L76.42,0.182L77.727,0.197L79.034,0.214L80.341,0.232L81.648,0.251L82.955,0.272L83.243,0.277L84.263,0.295L85.57,0.32L86.877,0.347L88.184,0.377L89.491,0.408L90.798,0.443L92.105,0.48L93.412,0.52L94.719,0.564L96.026,0.612L97.333,0.663L98.64,0.719L99.947,0.78L101.254,0.845L102.562,0.916L103.869,0.993L105.176,1.077L106.483,1.167L107.79,1.265L109.097,1.371L110.404,1.486L111.711,1.61L113.018,1.745L114.325,1.891L115.632,2.049L116.939,2.22L118.246,2.406L119.394,2.581L119.554,2.606L120.861,2.823L122.168,3.058L123.475,3.312L124.782,3.587L126.089,3.884L127.396,4.205L128.703,4.552L130.01,4.927L131.317,5.332L132.624,5.769L133.931,6.241L135.238,6.751L136.546,7.3L137.853,7.892L139.16,8.53L140.467,9.217L141.774,9.957L143.081,10.753L144.388,11.608L145.695,12.527L147.002,13.514L148.309,14.572L149.616,15.706L150.923,16.92L152.23,18.219L153.537,19.607L154.845,21.088L155.504,21.872L156.152,22.667L157.459,24.349L158.766,26.136L160.073,28.034L161.38,30.046L162.687,32.175L163.994,34.425L165.301,36.798L166.608,39.295L167.915,41.918L169.222,44.667L170.529,47.543L171.837,50.544L173.144,53.667L174.451,56.91L175.758,60.268L177.065,63.735L178.372,67.307L179.679,70.974L180.986,74.728L182.293,78.56L183.6,82.46L184.907,86.415L186.214,90.414L187.521,94.444L188.829,98.492L190.136,102.545L191.443,106.59L191.629,107.166L192.75,110.614L194.057,114.603L195.364,118.544L196.671,122.428L197.978,126.241L199.285,129.974L200.592,133.617L201.899,137.163L203.206,140.603L204.513,143.932L205.82,147.145L207.128,150.237L208.435,153.205L209.742,156.049L211.049,158.766L212.356,161.357L213.663,163.822L214.97,166.163L216.277,168.381L217.584,170.48L218.891,172.463L220.198,174.332L221.505,176.092L222.812,177.747L224.12,179.3L225.427,180.757L226.734,182.122L227.753,183.125L228.041,183.399L229.348,184.592L230.655,185.706L231.962,186.746L233.269,187.714L234.576,188.617L235.883,189.456L237.19,190.237L238.497,190.963L239.804,191.638L241.112,192.264L242.419,192.845L243.726,193.384L245.033,193.883L246.34,194.346L247.647,194.775L248.954,195.172L250.261,195.54L251.568,195.88L252.875,196.194L254.182,196.486L255.489,196.755L256.796,197.004L258.103,197.234L259.411,197.447L260.718,197.643L262.025,197.825L263.332,197.992L263.876,198.058L264.639,198.147L265.946,198.29L267.253,198.422L268.56,198.544L269.867,198.657L271.174,198.761L272.481,198.857L273.788,198.945L275.095,199.027L276.403,199.103L277.71,199.172L279.017,199.236L280.324,199.296L281.631,199.35L282.938,199.401L284.245,199.447L285.552,199.49" stroke="#edc949" stroke-width="1.5"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z"/><g><g class="mark-line role-mark layer_0_marks" role="graphics-object" aria-roledescription="line mark container"><path aria-label="Concentration (µg/mL): 3e-4; Fraction Infectivity: 0.999989799834; Antibody: HENV-103" role="graphics-symbol" aria-roledescription="line mark" d="M25.444,0.002L26.751,0.002L28.058,0.003L29.365,0.003L30.672,0.003L31.98,0.003L33.287,0.004L34.594,0.004L35.901,0.005L37.208,0.005L38.515,0.006L39.822,0.006L41.129,0.007L42.436,0.008L43.743,0.009L45.05,0.01L46.357,0.011L47.12,0.012L47.664,0.012L48.971,0.013L50.279,0.015L51.586,0.016L52.893,0.018L54.2,0.02L55.507,0.022L56.814,0.025L58.121,0.028L59.428,0.031L60.735,0.034L62.042,0.038L63.349,0.042L64.656,0.047L65.963,0.052L67.271,0.057L68.578,0.064L69.885,0.071L71.192,0.079L72.499,0.087L73.806,0.097L75.113,0.107L76.42,0.119L77.727,0.132L79.034,0.147L80.341,0.163L81.648,0.181L82.955,0.201L83.243,0.205L84.263,0.223L85.57,0.247L86.877,0.275L88.184,0.305L89.491,0.338L90.798,0.375L92.105,0.416L93.412,0.462L94.719,0.513L96.026,0.569L97.333,0.631L98.64,0.701L99.947,0.777L101.254,0.862L102.562,0.957L103.869,1.061L105.176,1.177L106.483,1.306L107.79,1.449L109.097,1.607L110.404,1.782L111.711,1.976L113.018,2.191L114.325,2.429L115.632,2.692L116.939,2.984L118.246,3.306L119.394,3.618L119.554,3.663L120.861,4.058L122.168,4.494L123.475,4.976L124.782,5.508L126.089,6.095L127.396,6.743L128.703,7.457L130.01,8.243L131.317,9.108L132.624,10.059L133.931,11.104L135.238,12.25L136.546,13.507L137.853,14.881L139.16,16.384L140.467,18.023L141.774,19.809L143.081,21.75L144.388,23.856L145.695,26.137L147.002,28.6L148.309,31.254L149.616,34.104L150.923,37.158L152.23,40.418L153.537,43.887L154.845,47.566L155.504,49.5L156.152,51.451L157.459,55.537L158.766,59.818L160.073,64.281L161.38,68.914L162.687,73.7L163.994,78.619L165.301,83.648L166.608,88.764L167.915,93.94L169.222,99.149L170.529,104.363L171.837,109.553L173.144,114.691L174.451,119.752L175.758,124.709L177.065,129.54L178.372,134.225L179.679,138.746L180.986,143.087L182.293,147.238L183.6,151.19L184.907,154.936L186.214,158.473L187.521,161.802L188.829,164.922L190.136,167.839L191.443,170.556L191.629,170.928L192.75,173.08L194.057,175.419L195.364,177.582L196.671,179.576L197.978,181.411L199.285,183.097L200.592,184.643L201.899,186.058L203.206,187.352L204.513,188.533L205.82,189.61L207.128,190.591L208.435,191.484L209.742,192.295L211.049,193.032L212.356,193.7L213.663,194.307L214.97,194.856L216.277,195.354L217.584,195.805L218.891,196.212L220.198,196.581L221.505,196.915L222.812,197.216L224.12,197.488L225.427,197.734L226.734,197.957L227.753,198.115L228.041,198.157L229.348,198.338L230.655,198.502L231.962,198.649L233.269,198.782L234.576,198.902L235.883,199.01L237.19,199.108L238.497,199.196L239.804,199.275L241.112,199.347L242.419,199.411L243.726,199.47L245.033,199.522L246.34,199.569L247.647,199.612L248.954,199.65L250.261,199.685L251.568,199.716L252.875,199.744L254.182,199.769L255.489,199.792L256.796,199.813L258.103,199.831L259.411,199.848L260.718,199.863L262.025,199.877L263.332,199.889L263.876,199.894L264.639,199.9L265.946,199.91L267.253,199.919L268.56,199.927L269.867,199.934L271.174,199.941L272.481,199.946L273.788,199.952L275.095,199.957L276.403,199.961L277.71,199.965L279.017,199.968L280.324,199.971L281.631,199.974L282.938,199.977L284.245,199.979L285.552,199.981" stroke="#e15759" stroke-width="1.5"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z"/><g><g class="mark-line role-mark layer_0_marks" role="graphics-object" aria-roledescription="line mark container"><path aria-label="Concentration (µg/mL): 3e-4; Fraction Infectivity: 0.999998312932; Antibody: HENV-117" role="graphics-symbol" aria-roledescription="line mark" d="M25.444,0L26.751,0L28.058,0L29.365,0.001L30.672,0.001L31.98,0.001L33.287,0.001L34.594,0.001L35.901,0.001L37.208,0.002L38.515,0.002L39.822,0.002L41.129,0.003L42.436,0.003L43.743,0.004L45.05,0.005L46.357,0.006L47.12,0.006L47.664,0.007L48.971,0.008L50.279,0.01L51.586,0.011L52.893,0.014L54.2,0.016L55.507,0.019L56.814,0.023L58.121,0.028L59.428,0.033L60.735,0.039L62.042,0.047L63.349,0.056L64.656,0.067L65.963,0.079L67.271,0.095L68.578,0.113L69.885,0.135L71.192,0.161L72.499,0.192L73.806,0.228L75.113,0.272L76.42,0.325L77.727,0.387L79.034,0.462L80.341,0.55L81.648,0.656L82.955,0.782L83.243,0.813L84.263,0.932L85.57,1.11L86.877,1.323L88.184,1.576L89.491,1.876L90.798,2.234L92.105,2.658L93.412,3.162L94.719,3.76L96.026,4.468L97.333,5.306L98.64,6.297L99.947,7.464L101.254,8.839L102.562,10.453L103.869,12.342L105.176,14.547L106.483,17.11L107.79,20.075L109.097,23.489L110.404,27.394L111.711,31.832L113.018,36.835L114.325,42.426L115.632,48.613L116.939,55.385L118.246,62.709L119.394,69.55L119.554,70.53L120.861,78.767L122.168,87.317L123.475,96.059L124.782,104.862L126.089,113.591L127.396,122.113L128.703,130.31L130.01,138.083L131.317,145.351L132.624,152.063L133.931,158.188L135.238,163.717L136.546,168.659L137.853,173.039L139.16,176.891L140.467,180.256L141.774,183.177L143.081,185.7L144.388,187.87L145.695,189.729L147.002,191.316L148.309,192.667L149.616,193.815L150.923,194.788L152.23,195.612L153.537,196.307L154.845,196.895L155.504,197.155L156.152,197.39L157.459,197.807L158.766,198.158L160.073,198.453L161.38,198.701L162.687,198.91L163.994,199.085L165.301,199.232L166.608,199.356L167.915,199.46L169.222,199.547L170.529,199.62L171.837,199.681L173.144,199.733L174.451,199.776L175.758,199.812L177.065,199.842L178.372,199.868L179.679,199.889L180.986,199.907L182.293,199.922L183.6,199.935L184.907,199.945L186.214,199.954L187.521,199.961L188.829,199.968L190.136,199.973L191.443,199.977L191.629,199.978L192.75,199.981L194.057,199.984L195.364,199.987L196.671,199.989L197.978,199.991L199.285,199.992L200.592,199.993L201.899,199.994L203.206,199.995L204.513,199.996L205.82,199.997L207.128,199.997L208.435,199.998L209.742,199.998L211.049,199.998L212.356,199.999L213.663,199.999L214.97,199.999L216.277,199.999L217.584,199.999L218.891,199.999L220.198,200L221.505,200L222.812,200L224.12,200L225.427,200L226.734,200L227.753,200L228.041,200L229.348,200L230.655,200L231.962,200L233.269,200L234.576,200L235.883,200L237.19,200L238.497,200L239.804,200L241.112,200L242.419,200L243.726,200L245.033,200L246.34,200L247.647,200L248.954,200L250.261,200L251.568,200L252.875,200L254.182,200L255.489,200L256.796,200L258.103,200L259.411,200L260.718,200L262.025,200L263.332,200L263.876,200L264.639,200L265.946,200L267.253,200L268.56,200L269.867,200L271.174,200L272.481,200L273.788,200L275.095,200L276.403,200L277.71,200L279.017,200L280.324,200L281.631,200L282.938,200L284.245,200L285.552,200" stroke="#76b7b2" stroke-width="1.5"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z"/><g><g class="mark-line role-mark layer_0_marks" role="graphics-object" aria-roledescription="line mark container"><path aria-label="Concentration (µg/mL): 3e-4; Fraction Infectivity: 0.999994187826; Antibody: EFNB2-monomeric" role="graphics-symbol" aria-roledescription="line mark" d="M25.444,0.001L26.751,0.001L28.058,0.001L29.365,0.002L30.672,0.002L31.98,0.002L33.287,0.002L34.594,0.003L35.901,0.003L37.208,0.003L38.515,0.004L39.822,0.004L41.129,0.005L42.436,0.005L43.743,0.006L45.05,0.006L46.357,0.007L47.12,0.008L47.664,0.008L48.971,0.009L50.279,0.01L51.586,0.011L52.893,0.013L54.2,0.014L55.507,0.016L56.814,0.018L58.121,0.02L59.428,0.023L60.735,0.025L62.042,0.028L63.349,0.032L64.656,0.036L65.963,0.04L67.271,0.045L68.578,0.05L69.885,0.056L71.192,0.063L72.499,0.07L73.806,0.079L75.113,0.088L76.42,0.099L77.727,0.111L79.034,0.124L80.341,0.139L81.648,0.156L82.955,0.175L83.243,0.179L84.263,0.196L85.57,0.22L86.877,0.246L88.184,0.276L89.491,0.309L90.798,0.347L92.105,0.388L93.412,0.435L94.719,0.487L96.026,0.546L97.333,0.612L98.64,0.685L99.947,0.768L101.254,0.86L102.562,0.964L103.869,1.079L105.176,1.209L106.483,1.354L107.79,1.516L109.097,1.697L110.404,1.9L111.711,2.128L113.018,2.381L114.325,2.665L115.632,2.982L116.939,3.336L118.246,3.731L119.394,4.116L119.554,4.172L120.861,4.664L122.168,5.213L123.475,5.824L124.782,6.504L126.089,7.261L127.396,8.102L128.703,9.036L130.01,10.072L131.317,11.22L132.624,12.49L133.931,13.893L135.238,15.44L136.546,17.145L137.853,19.018L139.16,21.072L140.467,23.32L141.774,25.772L143.081,28.441L144.388,31.337L145.695,34.469L147.002,37.843L148.309,41.464L149.616,45.336L150.923,49.456L152.23,53.82L153.537,58.42L154.845,63.242L155.504,65.755L156.152,68.271L157.459,73.486L158.766,78.859L160.073,84.364L161.38,89.968L162.687,95.636L163.994,101.332L165.301,107.02L166.608,112.662L167.915,118.224L169.222,123.671L170.529,128.974L171.837,134.104L173.144,139.039L174.451,143.76L175.758,148.251L177.065,152.502L178.372,156.506L179.679,160.26L180.986,163.766L182.293,167.025L183.6,170.046L184.907,172.834L186.214,175.401L187.521,177.756L188.829,179.912L190.136,181.88L191.443,183.672L191.629,183.915L192.75,185.302L194.057,186.781L195.364,188.12L196.671,189.332L197.978,190.426L199.285,191.413L200.592,192.302L201.899,193.103L203.206,193.823L204.513,194.47L205.82,195.051L207.128,195.572L208.435,196.04L209.742,196.459L211.049,196.834L212.356,197.171L213.663,197.472L214.97,197.741L216.277,197.982L217.584,198.197L218.891,198.39L220.198,198.562L221.505,198.716L222.812,198.854L224.12,198.976L225.427,199.086L226.734,199.184L227.753,199.253L228.041,199.272L229.348,199.35L230.655,199.42L231.962,199.482L233.269,199.538L234.576,199.587L235.883,199.632L237.19,199.671L238.497,199.707L239.804,199.738L241.112,199.766L242.419,199.792L243.726,199.814L245.033,199.834L246.34,199.852L247.647,199.868L248.954,199.882L250.261,199.895L251.568,199.906L252.875,199.916L254.182,199.925L255.489,199.933L256.796,199.94L258.103,199.947L259.411,199.953L260.718,199.958L262.025,199.962L263.332,199.966L263.876,199.968L264.639,199.97L265.946,199.973L267.253,199.976L268.56,199.979L269.867,199.981L271.174,199.983L272.481,199.985L273.788,199.986L275.095,199.988L276.403,199.989L277.71,199.99L279.017,199.991L280.324,199.992L281.631,199.993L282.938,199.994L284.245,199.995L285.552,199.995" stroke="#4e79a7" stroke-width="1.5"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z"/><g><g class="mark-line role-mark layer_0_marks" role="graphics-object" aria-roledescription="line mark container"><path aria-label="Concentration (µg/mL): 3e-4; Fraction Infectivity: 0.999991903952; Antibody: EFNB3-dimeric" role="graphics-symbol" aria-roledescription="line mark" d="M25.444,0.002L26.751,0.002L28.058,0.002L29.365,0.002L30.672,0.002L31.98,0.003L33.287,0.003L34.594,0.003L35.901,0.004L37.208,0.004L38.515,0.004L39.822,0.005L41.129,0.005L42.436,0.006L43.743,0.006L45.05,0.007L46.357,0.008L47.12,0.008L47.664,0.008L48.971,0.009L50.279,0.01L51.586,0.011L52.893,0.012L54.2,0.014L55.507,0.015L56.814,0.016L58.121,0.018L59.428,0.02L60.735,0.022L62.042,0.024L63.349,0.027L64.656,0.029L65.963,0.032L67.271,0.036L68.578,0.039L69.885,0.043L71.192,0.048L72.499,0.052L73.806,0.058L75.113,0.064L76.42,0.07L77.727,0.077L79.034,0.085L80.341,0.094L81.648,0.103L82.955,0.113L83.243,0.116L84.263,0.125L85.57,0.138L86.877,0.152L88.184,0.167L89.491,0.184L90.798,0.202L92.105,0.223L93.412,0.246L94.719,0.27L96.026,0.298L97.333,0.328L98.64,0.361L99.947,0.398L101.254,0.438L102.562,0.482L103.869,0.531L105.176,0.585L106.483,0.644L107.79,0.709L109.097,0.78L110.404,0.859L111.711,0.946L113.018,1.041L114.325,1.146L115.632,1.262L116.939,1.389L118.246,1.529L119.394,1.663L119.554,1.682L120.861,1.852L122.168,2.037L123.475,2.242L124.782,2.466L126.089,2.713L127.396,2.984L128.703,3.282L130.01,3.608L131.317,3.967L132.624,4.36L133.931,4.792L135.238,5.265L136.546,5.784L137.853,6.352L139.16,6.973L140.467,7.653L141.774,8.397L143.081,9.209L144.388,10.096L145.695,11.063L147.002,12.117L148.309,13.264L149.616,14.512L150.923,15.867L152.23,17.336L153.537,18.928L154.845,20.649L155.504,21.569L156.152,22.508L157.459,24.511L158.766,26.665L160.073,28.977L161.38,31.453L162.687,34.099L163.994,36.919L165.301,39.916L166.608,43.091L167.915,46.446L169.222,49.98L170.529,53.687L171.837,57.565L173.144,61.604L174.451,65.796L175.758,70.129L177.065,74.588L178.372,79.159L179.679,83.822L180.986,88.558L182.293,93.347L183.6,98.167L184.907,102.996L186.214,107.81L187.521,112.588L188.829,117.309L190.136,121.951L191.443,126.497L191.629,127.136L192.75,130.927L194.057,135.227L195.364,139.383L196.671,143.384L197.978,147.222L199.285,150.888L200.592,154.378L201.899,157.69L203.206,160.822L204.513,163.776L205.82,166.554L207.128,169.158L208.435,171.595L209.742,173.868L211.049,175.985L212.356,177.953L213.663,179.777L214.97,181.467L216.277,183.028L217.584,184.47L218.891,185.798L220.198,187.021L221.505,188.145L222.812,189.177L224.12,190.125L225.427,190.993L226.734,191.788L227.753,192.361L228.041,192.516L229.348,193.182L230.655,193.79L231.962,194.346L233.269,194.853L234.576,195.316L235.883,195.738L237.19,196.123L238.497,196.473L239.804,196.793L241.112,197.084L242.419,197.349L243.726,197.59L245.033,197.809L246.34,198.009L247.647,198.191L248.954,198.356L250.261,198.506L251.568,198.643L252.875,198.767L254.182,198.88L255.489,198.982L256.796,199.076L258.103,199.16L259.411,199.237L260.718,199.307L262.025,199.371L263.332,199.429L263.876,199.451L264.639,199.481L265.946,199.529L267.253,199.572L268.56,199.611L269.867,199.647L271.174,199.68L272.481,199.709L273.788,199.736L275.095,199.76L276.403,199.782L277.71,199.802L279.017,199.82L280.324,199.837L281.631,199.852L282.938,199.866L284.245,199.878L285.552,199.889" stroke="#f28e2c" stroke-width="1.5"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g></g><g class="mark-symbol role-mark layer_1_marks" role="graphics-object" aria-roledescription="symbol mark container"><path aria-label="Concentration (µg/mL): 6e-4; Fraction Infectivity: 0.922; Antibody: nAH1.3" role="graphics-symbol" aria-roledescription="circle" transform="translate(47.119790100646,15.600000000000014)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#ff9da7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-3; Fraction Infectivity: 0.9571; Antibody: nAH1.3" role="graphics-symbol" aria-roledescription="circle" transform="translate(83.24338958032376,8.579999999999988)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#ff9da7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 1e-2; Fraction Infectivity: 0.83905; Antibody: nAH1.3" role="graphics-symbol" aria-roledescription="circle" transform="translate(119.39367382312639,32.190000000000005)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#ff9da7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 4e-2; Fraction Infectivity: 0.2739; Antibody: nAH1.3" role="graphics-symbol" aria-roledescription="circle" transform="translate(155.50393433711014,145.22)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#ff9da7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-1; Fraction Infectivity: 0.00025; Antibody: nAH1.3" role="graphics-symbol" aria-roledescription="circle" transform="translate(191.62920156096675,199.95000000000002)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#ff9da7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-1; Fraction Infectivity: 0; Antibody: nAH1.3" role="graphics-symbol" aria-roledescription="circle" transform="translate(227.75280104064453,200)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#ff9da7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 3e+0; Fraction Infectivity: 0; Antibody: nAH1.3" role="graphics-symbol" aria-roledescription="circle" transform="translate(263.87640052032225,200)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#ff9da7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-4; Fraction Infectivity: 0.93595; Antibody: m102.4" role="graphics-symbol" aria-roledescription="circle" transform="translate(47.119790100646,12.809999999999988)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#af7aa1" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-3; Fraction Infectivity: 0.88365; Antibody: m102.4" role="graphics-symbol" aria-roledescription="circle" transform="translate(83.24338958032376,23.26999999999999)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#af7aa1" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 1e-2; Fraction Infectivity: 0.6371; Antibody: m102.4" role="graphics-symbol" aria-roledescription="circle" transform="translate(119.39367382312639,72.58)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#af7aa1" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 4e-2; Fraction Infectivity: 0.0538; Antibody: m102.4" role="graphics-symbol" aria-roledescription="circle" transform="translate(155.50393433711014,189.24)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#af7aa1" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-1; Fraction Infectivity: 0.00295; Antibody: m102.4" role="graphics-symbol" aria-roledescription="circle" transform="translate(191.62920156096675,199.41)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#af7aa1" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-1; Fraction Infectivity: 0.00045; Antibody: m102.4" role="graphics-symbol" aria-roledescription="circle" transform="translate(227.75280104064453,199.91)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#af7aa1" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 3e+0; Fraction Infectivity: 0; Antibody: m102.4" role="graphics-symbol" aria-roledescription="circle" transform="translate(263.87640052032225,200)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#af7aa1" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-4; Fraction Infectivity: 0.98265; Antibody: HENV-26" role="graphics-symbol" aria-roledescription="circle" transform="translate(47.119790100646,3.4699999999999953)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#59a14f" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-3; Fraction Infectivity: 0.91335; Antibody: HENV-26" role="graphics-symbol" aria-roledescription="circle" transform="translate(83.24338958032376,17.330000000000002)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#59a14f" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 1e-2; Fraction Infectivity: 0.70015; Antibody: HENV-26" role="graphics-symbol" aria-roledescription="circle" transform="translate(119.39367382312639,59.96999999999999)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#59a14f" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 4e-2; Fraction Infectivity: 0.0632; Antibody: HENV-26" role="graphics-symbol" aria-roledescription="circle" transform="translate(155.50393433711014,187.35999999999999)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#59a14f" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-1; Fraction Infectivity: 0; Antibody: HENV-26" role="graphics-symbol" aria-roledescription="circle" transform="translate(191.62920156096675,200)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#59a14f" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-1; Fraction Infectivity: 0; Antibody: HENV-26" role="graphics-symbol" aria-roledescription="circle" transform="translate(227.75280104064453,200)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#59a14f" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 3e+0; Fraction Infectivity: 0; Antibody: HENV-26" role="graphics-symbol" aria-roledescription="circle" transform="translate(263.87640052032225,200)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#59a14f" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-4; Fraction Infectivity: 1.00705; Antibody: HENV-32" role="graphics-symbol" aria-roledescription="circle" transform="translate(47.119790100646,-1.4100000000000001)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#edc949" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-3; Fraction Infectivity: 1.02475; Antibody: HENV-32" role="graphics-symbol" aria-roledescription="circle" transform="translate(83.24338958032376,-4.95000000000001)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#edc949" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 1e-2; Fraction Infectivity: 1.0155; Antibody: HENV-32" role="graphics-symbol" aria-roledescription="circle" transform="translate(119.39367382312639,-3.0999999999999694)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#edc949" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 4e-2; Fraction Infectivity: 0.88145; Antibody: HENV-32" role="graphics-symbol" aria-roledescription="circle" transform="translate(155.50393433711014,23.710000000000008)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#edc949" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-1; Fraction Infectivity: 0.4662; Antibody: HENV-32" role="graphics-symbol" aria-roledescription="circle" transform="translate(191.62920156096675,106.76)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#edc949" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-1; Fraction Infectivity: 0.0849; Antibody: HENV-32" role="graphics-symbol" aria-roledescription="circle" transform="translate(227.75280104064453,183.02)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#edc949" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 3e+0; Fraction Infectivity: 0.00455; Antibody: HENV-32" role="graphics-symbol" aria-roledescription="circle" transform="translate(263.87640052032225,199.08999999999997)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#edc949" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-4; Fraction Infectivity: 1.1104; Antibody: HENV-103" role="graphics-symbol" aria-roledescription="circle" transform="translate(47.119790100646,-22.080000000000013)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#e15759" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-3; Fraction Infectivity: 1.02955; Antibody: HENV-103" role="graphics-symbol" aria-roledescription="circle" transform="translate(83.24338958032376,-5.909999999999993)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#e15759" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 1e-2; Fraction Infectivity: 1.0765; Antibody: HENV-103" role="graphics-symbol" aria-roledescription="circle" transform="translate(119.39367382312639,-15.300000000000002)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#e15759" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 4e-2; Fraction Infectivity: 0.73365; Antibody: HENV-103" role="graphics-symbol" aria-roledescription="circle" transform="translate(155.50393433711014,53.27000000000002)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#e15759" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-1; Fraction Infectivity: 0.16005; Antibody: HENV-103" role="graphics-symbol" aria-roledescription="circle" transform="translate(191.62920156096675,167.99)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#e15759" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-1; Fraction Infectivity: 0.006; Antibody: HENV-103" role="graphics-symbol" aria-roledescription="circle" transform="translate(227.75280104064453,198.8)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#e15759" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 3e+0; Fraction Infectivity: 0.0009; Antibody: HENV-103" role="graphics-symbol" aria-roledescription="circle" transform="translate(263.87640052032225,199.82)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#e15759" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-4; Fraction Infectivity: 1.05235; Antibody: HENV-117" role="graphics-symbol" aria-roledescription="circle" transform="translate(47.119790100646,-10.470000000000024)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#76b7b2" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-3; Fraction Infectivity: 1.0248; Antibody: HENV-117" role="graphics-symbol" aria-roledescription="circle" transform="translate(83.24338958032376,-4.959999999999987)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#76b7b2" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 1e-2; Fraction Infectivity: 0.6512; Antibody: HENV-117" role="graphics-symbol" aria-roledescription="circle" transform="translate(119.39367382312639,69.76)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#76b7b2" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 4e-2; Fraction Infectivity: 0.0228; Antibody: HENV-117" role="graphics-symbol" aria-roledescription="circle" transform="translate(155.50393433711014,195.44)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#76b7b2" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-1; Fraction Infectivity: 0; Antibody: HENV-117" role="graphics-symbol" aria-roledescription="circle" transform="translate(191.62920156096675,200)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#76b7b2" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-1; Fraction Infectivity: 0; Antibody: HENV-117" role="graphics-symbol" aria-roledescription="circle" transform="translate(227.75280104064453,200)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#76b7b2" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 3e+0; Fraction Infectivity: 0; Antibody: HENV-117" role="graphics-symbol" aria-roledescription="circle" transform="translate(263.87640052032225,200)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#76b7b2" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-4; Fraction Infectivity: 1.0745; Antibody: EFNB2-monomeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(47.119790100646,-14.900000000000002)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#4e79a7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-3; Fraction Infectivity: 1.15255; Antibody: EFNB2-monomeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(83.24338958032376,-30.50999999999999)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#4e79a7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 1e-2; Fraction Infectivity: 1.03125; Antibody: EFNB2-monomeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(119.39367382312639,-6.25)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#4e79a7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 4e-2; Fraction Infectivity: 0.6598; Antibody: EFNB2-monomeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(155.50393433711014,68.04)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#4e79a7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-1; Fraction Infectivity: 0.0986; Antibody: EFNB2-monomeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(191.62920156096675,180.28)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#4e79a7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-1; Fraction Infectivity: 0.0016; Antibody: EFNB2-monomeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(227.75280104064453,199.67999999999998)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#4e79a7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 3e+0; Fraction Infectivity: 0; Antibody: EFNB2-monomeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(263.87640052032225,200)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#4e79a7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-4; Fraction Infectivity: 1.0811; Antibody: EFNB3-dimeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(47.119790100646,-16.220000000000034)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#f28e2c" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-3; Fraction Infectivity: 1.11225; Antibody: EFNB3-dimeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(83.24338958032376,-22.449999999999992)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#f28e2c" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 1e-2; Fraction Infectivity: 1.10965; Antibody: EFNB3-dimeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(119.39367382312639,-21.930000000000007)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#f28e2c" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 4e-2; Fraction Infectivity: 0.857; Antibody: EFNB3-dimeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(155.50393433711014,28.6)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#f28e2c" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-1; Fraction Infectivity: 0.3797; Antibody: EFNB3-dimeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(191.62920156096675,124.06000000000002)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#f28e2c" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-1; Fraction Infectivity: 0.00515; Antibody: EFNB3-dimeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(227.75280104064453,198.97)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#f28e2c" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 3e+0; Fraction Infectivity: 0.0002; Antibody: EFNB3-dimeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(263.87640052032225,199.96)" d="M2.739,0A2.739,2.739,0,1,1,-2.739,0A2.739,2.739,0,1,1,2.739,0" fill="#f28e2c" stroke-width="2" opacity="1"/></g><g class="mark-rule role-mark layer_2_marks" role="graphics-object" aria-roledescription="rule mark container"><line aria-label="concentration: 0.00061; Fraction Infectivity: 0.8966; upper_lower: 0.9474; Antibody: nAH1.3; upper: 0.9474; lower: 0.8966" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(47.119790100646,20.68000000000003)" x2="0" y2="-10.160000000000036" stroke="#ff9da7" opacity="1"/><line aria-label="concentration: 0.00244; Fraction Infectivity: 0.935; upper_lower: 0.9792; Antibody: nAH1.3; upper: 0.9792; lower: 0.935" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(83.24338958032376,12.999999999999968)" x2="0" y2="-8.83999999999996" stroke="#ff9da7" opacity="1"/><line aria-label="concentration: 0.00977; Fraction Infectivity: 0.7908; upper_lower: 0.8873; Antibody: nAH1.3; upper: 0.8873; lower: 0.7908" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(119.39367382312639,41.84000000000001)" x2="0" y2="-19.300000000000004" stroke="#ff9da7" opacity="1"/><line aria-label="concentration: 0.03906; Fraction Infectivity: 0.2105; upper_lower: 0.3373; Antibody: nAH1.3; upper: 0.3373; lower: 0.2105" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(155.50393433711014,157.9)" x2="0" y2="-25.359999999999985" stroke="#ff9da7" opacity="1"/><line aria-label="concentration: 0.15625; Fraction Infectivity: 0; upper_lower: 0.0005; Antibody: nAH1.3; upper: 0.0005; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(191.62920156096675,200)" x2="0" y2="-0.09999999999999432" stroke="#ff9da7" opacity="1"/><line aria-label="concentration: 0.625; Fraction Infectivity: 0; upper_lower: 0; Antibody: nAH1.3; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(227.75280104064453,200)" x2="0" y2="0" stroke="#ff9da7" opacity="1"/><line aria-label="concentration: 2.5; Fraction Infectivity: 0; upper_lower: 0; Antibody: nAH1.3; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(263.87640052032225,200)" x2="0" y2="0" stroke="#ff9da7" opacity="1"/><line aria-label="concentration: 0.00061; Fraction Infectivity: 0.8997; upper_lower: 0.9722; Antibody: m102.4; upper: 0.9722; lower: 0.8997" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(47.119790100646,20.059999999999988)" x2="0" y2="-14.5" stroke="#af7aa1" opacity="1"/><line aria-label="concentration: 0.00244; Fraction Infectivity: 0.8744; upper_lower: 0.8929; Antibody: m102.4; upper: 0.8929; lower: 0.8744" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(83.24338958032376,25.120000000000008)" x2="0" y2="-3.700000000000035" stroke="#af7aa1" opacity="1"/><line aria-label="concentration: 0.00977; Fraction Infectivity: 0.6145; upper_lower: 0.6597; Antibody: m102.4; upper: 0.6597; lower: 0.6145" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(119.39367382312639,77.1)" x2="0" y2="-9.039999999999992" stroke="#af7aa1" opacity="1"/><line aria-label="concentration: 0.03906; Fraction Infectivity: 0.0419; upper_lower: 0.0657; Antibody: m102.4; upper: 0.0657; lower: 0.0419" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(155.50393433711014,191.62)" x2="0" y2="-4.759999999999991" stroke="#af7aa1" opacity="1"/><line aria-label="concentration: 0.15625; Fraction Infectivity: 0.0023; upper_lower: 0.0036; Antibody: m102.4; upper: 0.0036; lower: 0.0023" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(191.62920156096675,199.54000000000002)" x2="0" y2="-0.2600000000000193" stroke="#af7aa1" opacity="1"/><line aria-label="concentration: 0.625; Fraction Infectivity: 0.0003; upper_lower: 0.0006; Antibody: m102.4; upper: 0.0006; lower: 0.0003" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(227.75280104064453,199.94)" x2="0" y2="-0.060000000000002274" stroke="#af7aa1" opacity="1"/><line aria-label="concentration: 2.5; Fraction Infectivity: 0; upper_lower: 0; Antibody: m102.4; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(263.87640052032225,200)" x2="0" y2="0" stroke="#af7aa1" opacity="1"/><line aria-label="concentration: 0.00061; Fraction Infectivity: 0.9752; upper_lower: 0.9901; Antibody: HENV-26; upper: 0.9901; lower: 0.9752" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(47.119790100646,4.959999999999987)" x2="0" y2="-2.9799999999999827" stroke="#59a14f" opacity="1"/><line aria-label="concentration: 0.00244; Fraction Infectivity: 0.902; upper_lower: 0.9247; Antibody: HENV-26; upper: 0.9247; lower: 0.902" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(83.24338958032376,19.599999999999994)" x2="0" y2="-4.5399999999999885" stroke="#59a14f" opacity="1"/><line aria-label="concentration: 0.00977; Fraction Infectivity: 0.6741; upper_lower: 0.7262; Antibody: HENV-26; upper: 0.7262; lower: 0.6741" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(119.39367382312639,65.17999999999999)" x2="0" y2="-10.420000000000009" stroke="#59a14f" opacity="1"/><line aria-label="concentration: 0.03906; Fraction Infectivity: 0.0514; upper_lower: 0.075; Antibody: HENV-26; upper: 0.075; lower: 0.0514" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(155.50393433711014,189.72)" x2="0" y2="-4.719999999999999" stroke="#59a14f" opacity="1"/><line aria-label="concentration: 0.15625; Fraction Infectivity: 0; upper_lower: 0; Antibody: HENV-26; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(191.62920156096675,200)" x2="0" y2="0" stroke="#59a14f" opacity="1"/><line aria-label="concentration: 0.625; Fraction Infectivity: 0; upper_lower: 0; Antibody: HENV-26; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(227.75280104064453,200)" x2="0" y2="0" stroke="#59a14f" opacity="1"/><line aria-label="concentration: 2.5; Fraction Infectivity: 0; upper_lower: 0; Antibody: HENV-26; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(263.87640052032225,200)" x2="0" y2="0" stroke="#59a14f" opacity="1"/><line aria-label="concentration: 0.00061; Fraction Infectivity: 0.9851; upper_lower: 1.029; Antibody: HENV-32; upper: 1.029; lower: 0.9851" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(47.119790100646,2.980000000000005)" x2="0" y2="-8.779999999999987" stroke="#edc949" opacity="1"/><line aria-label="concentration: 0.00244; Fraction Infectivity: 1.0211; upper_lower: 1.0284; Antibody: HENV-32; upper: 1.0284; lower: 1.0211" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(83.24338958032376,-4.219999999999979)" x2="0" y2="-1.4600000000000612" stroke="#edc949" opacity="1"/><line aria-label="concentration: 0.00977; Fraction Infectivity: 1.0061; upper_lower: 1.0249; Antibody: HENV-32; upper: 1.0249; lower: 1.0061" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(119.39367382312639,-1.2199999999999545)" x2="0" y2="-3.76000000000003" stroke="#edc949" opacity="1"/><line aria-label="concentration: 0.03906; Fraction Infectivity: 0.8754; upper_lower: 0.8875; Antibody: HENV-32; upper: 0.8875; lower: 0.8754" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(155.50393433711014,24.92000000000001)" x2="0" y2="-2.4200000000000017" stroke="#edc949" opacity="1"/><line aria-label="concentration: 0.15625; Fraction Infectivity: 0.457; upper_lower: 0.4754; Antibody: HENV-32; upper: 0.4754; lower: 0.457" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(191.62920156096675,108.59999999999998)" x2="0" y2="-3.6799999999999926" stroke="#edc949" opacity="1"/><line aria-label="concentration: 0.625; Fraction Infectivity: 0.0832; upper_lower: 0.0866; Antibody: HENV-32; upper: 0.0866; lower: 0.0832" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(227.75280104064453,183.36)" x2="0" y2="-0.6800000000000068" stroke="#edc949" opacity="1"/><line aria-label="concentration: 2.5; Fraction Infectivity: 0.0036; upper_lower: 0.0055; Antibody: HENV-32; upper: 0.0055; lower: 0.0036" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(263.87640052032225,199.28)" x2="0" y2="-0.37999999999999545" stroke="#edc949" opacity="1"/><line aria-label="concentration: 0.00061; Fraction Infectivity: 1.0822; upper_lower: 1.1386; Antibody: HENV-103; upper: 1.1386; lower: 1.0822" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(47.119790100646,-16.440000000000012)" x2="0" y2="-11.280000000000001" stroke="#e15759" opacity="1"/><line aria-label="concentration: 0.00244; Fraction Infectivity: 1.0095; upper_lower: 1.0496; Antibody: HENV-103; upper: 1.0496; lower: 1.0095" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(83.24338958032376,-1.8999999999999684)" x2="0" y2="-8.02000000000005" stroke="#e15759" opacity="1"/><line aria-label="concentration: 0.00977; Fraction Infectivity: 1.0609; upper_lower: 1.0921; Antibody: HENV-103; upper: 1.0921; lower: 1.0609" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(119.39367382312639,-12.17999999999999)" x2="0" y2="-6.240000000000025" stroke="#e15759" opacity="1"/><line aria-label="concentration: 0.03906; Fraction Infectivity: 0.689; upper_lower: 0.7783; Antibody: HENV-103; upper: 0.7783; lower: 0.689" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(155.50393433711014,62.20000000000003)" x2="0" y2="-17.860000000000028" stroke="#e15759" opacity="1"/><line aria-label="concentration: 0.15625; Fraction Infectivity: 0.1517; upper_lower: 0.1684; Antibody: HENV-103; upper: 0.1684; lower: 0.1517" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(191.62920156096675,169.66000000000003)" x2="0" y2="-3.340000000000032" stroke="#e15759" opacity="1"/><line aria-label="concentration: 0.625; Fraction Infectivity: 0.0051; upper_lower: 0.0069; Antibody: HENV-103; upper: 0.0069; lower: 0.0051" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(227.75280104064453,198.98)" x2="0" y2="-0.3599999999999852" stroke="#e15759" opacity="1"/><line aria-label="concentration: 2.5; Fraction Infectivity: 0.0004; upper_lower: 0.0014; Antibody: HENV-103; upper: 0.0014; lower: 0.0004" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(263.87640052032225,199.92000000000002)" x2="0" y2="-0.20000000000001705" stroke="#e15759" opacity="1"/><line aria-label="concentration: 0.00061; Fraction Infectivity: 1.0345; upper_lower: 1.0702; Antibody: HENV-117; upper: 1.0702; lower: 1.0345" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(47.119790100646,-6.899999999999995)" x2="0" y2="-7.140000000000057" stroke="#76b7b2" opacity="1"/><line aria-label="concentration: 0.00244; Fraction Infectivity: 0.986; upper_lower: 1.0636; Antibody: HENV-117; upper: 1.0636; lower: 0.986" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(83.24338958032376,2.800000000000047)" x2="0" y2="-15.520000000000067" stroke="#76b7b2" opacity="1"/><line aria-label="concentration: 0.00977; Fraction Infectivity: 0.6177; upper_lower: 0.6847; Antibody: HENV-117; upper: 0.6847; lower: 0.6177" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(119.39367382312639,76.46)" x2="0" y2="-13.399999999999991" stroke="#76b7b2" opacity="1"/><line aria-label="concentration: 0.03906; Fraction Infectivity: 0.0188; upper_lower: 0.0268; Antibody: HENV-117; upper: 0.0268; lower: 0.0188" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(155.50393433711014,196.23999999999998)" x2="0" y2="-1.5999999999999943" stroke="#76b7b2" opacity="1"/><line aria-label="concentration: 0.15625; Fraction Infectivity: 0; upper_lower: 0; Antibody: HENV-117; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(191.62920156096675,200)" x2="0" y2="0" stroke="#76b7b2" opacity="1"/><line aria-label="concentration: 0.625; Fraction Infectivity: 0; upper_lower: 0; Antibody: HENV-117; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(227.75280104064453,200)" x2="0" y2="0" stroke="#76b7b2" opacity="1"/><line aria-label="concentration: 2.5; Fraction Infectivity: 0; upper_lower: 0; Antibody: HENV-117; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(263.87640052032225,200)" x2="0" y2="0" stroke="#76b7b2" opacity="1"/><line aria-label="concentration: 0.00061; Fraction Infectivity: 1.051; upper_lower: 1.098; Antibody: EFNB2-monomeric; upper: 1.098; lower: 1.051" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(47.119790100646,-10.199999999999987)" x2="0" y2="-9.400000000000029" stroke="#4e79a7" opacity="1"/><line aria-label="concentration: 0.00244; Fraction Infectivity: 1.1309; upper_lower: 1.1742; Antibody: EFNB2-monomeric; upper: 1.1742; lower: 1.1309" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(83.24338958032376,-26.180000000000003)" x2="0" y2="-8.659999999999979" stroke="#4e79a7" opacity="1"/><line aria-label="concentration: 0.00977; Fraction Infectivity: 1.0181; upper_lower: 1.0444; Antibody: EFNB2-monomeric; upper: 1.0444; lower: 1.0181" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(119.39367382312639,-3.620000000000001)" x2="0" y2="-5.259999999999998" stroke="#4e79a7" opacity="1"/><line aria-label="concentration: 0.03906; Fraction Infectivity: 0.6209; upper_lower: 0.6987; Antibody: EFNB2-monomeric; upper: 0.6987; lower: 0.6209" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(155.50393433711014,75.82)" x2="0" y2="-15.559999999999967" stroke="#4e79a7" opacity="1"/><line aria-label="concentration: 0.15625; Fraction Infectivity: 0.0903; upper_lower: 0.1069; Antibody: EFNB2-monomeric; upper: 0.1069; lower: 0.0903" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(191.62920156096675,181.94)" x2="0" y2="-3.319999999999993" stroke="#4e79a7" opacity="1"/><line aria-label="concentration: 0.625; Fraction Infectivity: 0.0013; upper_lower: 0.0019; Antibody: EFNB2-monomeric; upper: 0.0019; lower: 0.0013" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(227.75280104064453,199.74)" x2="0" y2="-0.12000000000000455" stroke="#4e79a7" opacity="1"/><line aria-label="concentration: 2.5; Fraction Infectivity: 0; upper_lower: 0; Antibody: EFNB2-monomeric; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(263.87640052032225,200)" x2="0" y2="0" stroke="#4e79a7" opacity="1"/><line aria-label="concentration: 0.00061; Fraction Infectivity: 1.0805; upper_lower: 1.0817; Antibody: EFNB3-dimeric; upper: 1.0817; lower: 1.0805" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(47.119790100646,-16.100000000000048)" x2="0" y2="-0.23999999999997357" stroke="#f28e2c" opacity="1"/><line aria-label="concentration: 0.00244; Fraction Infectivity: 1.1084; upper_lower: 1.1161; Antibody: EFNB3-dimeric; upper: 1.1161; lower: 1.1084" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(83.24338958032376,-21.679999999999964)" x2="0" y2="-1.540000000000056" stroke="#f28e2c" opacity="1"/><line aria-label="concentration: 0.00977; Fraction Infectivity: 1.1068; upper_lower: 1.1125; Antibody: EFNB3-dimeric; upper: 1.1125; lower: 1.1068" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(119.39367382312639,-21.36)" x2="0" y2="-1.1400000000000077" stroke="#f28e2c" opacity="1"/><line aria-label="concentration: 0.03906; Fraction Infectivity: 0.8253; upper_lower: 0.8887; Antibody: EFNB3-dimeric; upper: 0.8887; lower: 0.8253" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(155.50393433711014,34.93999999999999)" x2="0" y2="-12.679999999999978" stroke="#f28e2c" opacity="1"/><line aria-label="concentration: 0.15625; Fraction Infectivity: 0.362; upper_lower: 0.3974; Antibody: EFNB3-dimeric; upper: 0.3974; lower: 0.362" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(191.62920156096675,127.60000000000001)" x2="0" y2="-7.079999999999998" stroke="#f28e2c" opacity="1"/><line aria-label="concentration: 0.625; Fraction Infectivity: 0.0048; upper_lower: 0.0055; Antibody: EFNB3-dimeric; upper: 0.0055; lower: 0.0048" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(227.75280104064453,199.04)" x2="0" y2="-0.13999999999998636" stroke="#f28e2c" opacity="1"/><line aria-label="concentration: 2.5; Fraction Infectivity: 0.0002; upper_lower: 0.0002; Antibody: EFNB3-dimeric; upper: 0.0002; lower: 0.0002" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(263.87640052032225,199.96)" x2="0" y2="0" stroke="#f28e2c" opacity="1"/></g><g class="mark-group role-legend" role="graphics-symbol" aria-roledescription="legend" aria-label="Symbol legend titled 'Antibody' for fill color and stroke color with 8 values: EFNB2-monomeric, EFNB3-dimeric, HENV-103, HENV-117, HENV-26, ending with nAH1.3"><g transform="translate(318,0)"><path class="background" aria-hidden="true" d="M0,0h148v155h-148Z" pointer-events="none"/><g><g class="mark-group role-legend-entry"><g transform="translate(5,24)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-group role-scope" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h137.02734375v14h-137.02734375Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(7,7)" d="M5,0A5,5,0,1,1,-5,0A5,5,0,1,1,5,0" fill="#4e79a7" stroke="#4e79a7" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(18,11)" font-family="Helvetica" font-size="14px" fill="#000" opacity="1">EFNB2-monomeric</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(0,16)"><path class="background" aria-hidden="true" d="M0,0h137.02734375v14h-137.02734375Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(7,7)" d="M5,0A5,5,0,1,1,-5,0A5,5,0,1,1,5,0" fill="#f28e2c" stroke="#f28e2c" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(18,11)" font-family="Helvetica" font-size="14px" fill="#000" opacity="1">EFNB3-dimeric</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(0,32)"><path class="background" aria-hidden="true" d="M0,0h137.02734375v14h-137.02734375Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(7,7)" d="M5,0A5,5,0,1,1,-5,0A5,5,0,1,1,5,0" fill="#e15759" stroke="#e15759" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(18,11)" font-family="Helvetica" font-size="14px" fill="#000" opacity="1">HENV-103</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(0,48)"><path class="background" aria-hidden="true" d="M0,0h137.02734375v14h-137.02734375Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(7,7)" d="M5,0A5,5,0,1,1,-5,0A5,5,0,1,1,5,0" fill="#76b7b2" stroke="#76b7b2" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(18,11)" font-family="Helvetica" font-size="14px" fill="#000" opacity="1">HENV-117</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(0,64)"><path class="background" aria-hidden="true" d="M0,0h137.02734375v14h-137.02734375Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(7,7)" d="M5,0A5,5,0,1,1,-5,0A5,5,0,1,1,5,0" fill="#59a14f" stroke="#59a14f" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(18,11)" font-family="Helvetica" font-size="14px" fill="#000" opacity="1">HENV-26</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(0,80)"><path class="background" aria-hidden="true" d="M0,0h137.02734375v14h-137.02734375Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(7,7)" d="M5,0A5,5,0,1,1,-5,0A5,5,0,1,1,5,0" fill="#edc949" stroke="#edc949" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(18,11)" font-family="Helvetica" font-size="14px" fill="#000" opacity="1">HENV-32</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(0,96)"><path class="background" aria-hidden="true" d="M0,0h137.02734375v14h-137.02734375Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(7,7)" d="M5,0A5,5,0,1,1,-5,0A5,5,0,1,1,5,0" fill="#af7aa1" stroke="#af7aa1" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(18,11)" font-family="Helvetica" font-size="14px" fill="#000" opacity="1">m102.4</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(0,112)"><path class="background" aria-hidden="true" d="M0,0h137.02734375v14h-137.02734375Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(7,7)" d="M5,0A5,5,0,1,1,-5,0A5,5,0,1,1,5,0" fill="#ff9da7" stroke="#ff9da7" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(18,11)" font-family="Helvetica" font-size="14px" fill="#000" opacity="1">nAH1.3</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-text role-legend-title" pointer-events="none"><text text-anchor="start" transform="translate(5,16)" font-family="Helvetica" font-size="14px" font-weight="bold" fill="#000" opacity="1">Antibody</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g></g></g></svg>